Nasal carriage of methicillin resistant  among health care workers at Al Shifa hospital in Gaza Strip by unknown
RESEARCH ARTICLE Open Access
Nasal carriage of methicillin resistant
Staphylococcus aureus among health care
workers at Al Shifa hospital in Gaza Strip
Nabil Abdullah El Aila1*, Nahed Ali Al Laham2 and Basim Mohammad Ayesh1
Abstract
Background: Nasal carriage of Staphylococcus aureus among hospital personnel is a common cause of hospital
acquired infections. Emergence of drug resistant strains especially methicillin resistant S. aureus (MRSA) is a serious
problem in hospital environment. Therefore, the aim of this study was to determine the nasal carriage rate of S.
aureus and MRSA among Health Care Workers (HCWs) at Al Shifa Hospital, the major hospital in Gaza Strip.
Methods: A cross sectional study was conducted on 200 HCWs. Nasal swabs were collected during February— April
2015, and cultured on blood and mannitol salt agar. The isolates were identified as S. aureus based on morphology,
coagulase test, DNase test and mannitol salt agar fermentation. Disk diffusion antibiotic susceptibility tests were
performed according to the guidelines of the Clinical and Laboratory Standards Institute. MRSA were confirmed by
detection of the mecA gene by PCR.
Results: Out of the 200 healthcare workers, 62 (31%) carried S. aureus, of which 51 (82.3%) were MRSA. Therefore,
25.5% of all HCWs were identified as MRSA carriers. MRSA carriage rate was highest among nurses (30.4%)
whereas the carriage rate among doctors was (16%). The majority of MRSA carriers were workers of internal
medicine department and surgical wards (41.3 and 35% respectively). Out of the 51 MRSA isolates identified by
oxacillin disc resistance, 40 were confirmed by PCR targeting the mecA gene. Penicillin showed the highest rate
of resistance among MRSA and MSSA isolates (100%).
Conclusions: The high rate of nasal MRSA carriage among healthcare workers found in this study is alarming and
highlights the need for adjusted infection control measures to prevent MRSA transmission from HCWs to the
vulnerable patient.
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Background
MRSA is a major nosocomial pathogen that causes
severe morbidity and mortality worldwide [1]. It has
emerged as one of the commonest causes of hospital
acquired infection and continues to remain an important
factor contributing to failure of management [2].
Nasal carriage of S. aureus appears to play a key role
in the epidemiology and pathogenesis of infection [3].
HCWs who are at interface between the hospital and the
community may serve as agents of cross contamination
of hospital acquired and community acquired MRSA [4].
Knowledge of the prevalence of MRSA and its anti-
microbial profile is necessary for selection of the appro-
priate empirical antimicrobial treatment for S. aureus
infections [5]. In particular, screening for and eradication
of MRSA from colonized HCWs have been recognized
and recommended as an important part of a compre-
hensive infection control policy for this organism.
In 2007, a Mediterranean study found that the highest
proportions of MRSA were reported by Egypt (52%),
Cyprus (55%), Algeria (45%), Malta (50%) and Jordan
(56%), in comparison to other Mediterranean countries
such as Lebanon (12%), Tunisia (18%) and Morocco
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(19%) [6]. However, few reports are available about the
epidemiology of S. aureus and MRSA in HCWs in
Palestine. Several studies reported the prevalence of S.
aureus in Palestine on a hospital— and community-
acquired basis [7–12]. Al Laham et al recently reported
MRSA carriage rate of 22.6% among HCWs in three
different hospitals in Gaza Strip [13].
In this follow up study we report the prevalence of S.
aureus and MRSA carriage in a larger group of HCWs
from Al Shifa hospital with emphasis on its distribution
based on different health care professions. Furthermore,
we describe the antibiotic susceptibility patterns of the S.
aureus and MRSA isolates. The outcomes of the study
are useful for formulating a MRSA infection control
policy in hospitals of Gaza strip.
Methods
Study design
A cross sectional study involving 200 health care
personnel who are working at different departments in
Al Shifa hospital during the period from February to
April 2015.
HCWs with a history of upper respiratory tract infec-
tion, fever, recent nasal surgery, diabetes, use of nasal
medications or antimicrobial therapy and immunocom-
promised patients were excluded.
The study was approved by the Ministry of Health,
and an informed consent was obtained from each
participant.
Collection and culture of specimens
Nasal swabs were collected from the anterior nares of
the HCWs using a cotton swab in AMIES transport
medium.
The swab was inserted into each nostril in turn to
a depth of approximately one cm and rotated 4–5
times both clockwise and counterclockwise. The
swabs were immediately transported to the microbiol-
ogy laboratory for further processing. Specimens were
inoculated onto Blood agar and incubated overnight
at 37 °C. Suspected colonies of S. aureus were con-
firmed by morphology, Gram stain, catalase test,
fermentation of Mannitol salt agar, DNAse production
on DNA agar and coagulase tests.
Antibiotic susceptibility testing of all isolates was per-
formed by modified Kirby Bauer disc diffusion method
as recommended by CLSI guidelines [14] using Mueller-
Hinton agar. The antibiotics used in this study were
penicillin (10 Units), amoxicillin-calvulanic (30 μg) acid,
erythromycin (15 μg), vancomycin (30 μg), tetracycline
(30 μg), cefuroxime (30 μg), gentamycin (10 μg), rifampi-
cin (5 μg), clindamycin (2 μg), and ciprofloxacin (5 μg)
(Himedia - India). Methicillin resistance was detected
using oxacillin (1 μg) disc diffusion test. Briefly, single
isolated colonies were selected and inoculated in Mueller-
Hinton broth until its turbidity is comparable to 0.5
McFarland turbidity standard. Then the plates were inocu-
lated with each broth culture and left to dry at room
temperature before the application of antibiotic discs.
The plates were incubated at 35 ± 2 °C in ambient air
for 16–18 h. Plates with oxacillin were incubated at
33–35 °C because testing at temperatures above 35 °C
may not detect MRSA as recommended by CLSI guide-
lines [14]. Zone of inhibition for each antimicrobial agent
was interpreted, reporting the organism as resistant, inter-
mediate or susceptible. S. aureus ATCC 33,592 (mecA
positive, resistant) and S. aureus ATCC 29,213 (mecA
negative, susceptible) were used as quality control strains.
DNA extraction from isolates
DNA was extracted from cultured isolates by alkaline
lysis as previously described [15]. Briefly, one bacterial
colony was suspended in 20 μl of lysis buffer (0.25%
sodium dodecyl sulfate, 0.05 N NaOH) and heated at
95 °C for 15 min. The cell lysate was diluted by 180 μl of
distilled water. The cell debris was pelted by centrifuga-
tion at 16,000 xg for 5 min. and the supernatants were
used for PCR or frozen at −20 °C until further use.
Detection of mecA gene by PCR
The mecA gene and femA endogenous control gene
were simultaneously amplified in the same reaction.
The primers used to amplify the mecA gene were (for-
ward: 5’- AAGCGACTTCATCTATTAGGTTAT-3’ and
reverse: 5’-TATATTCTTCGTTACTCATGCCATAC-3’;
[16]. The primers used to amplify the femA gene were
(forward: 5’-AACTGTTGGCCACTATGAGT-3’ and re-
verse: 5’-CCAGCATTACCTGTAATCTCG-3’; [17]. The
reactions were performed in 25 μl final volumes in the
presence of 1 μM of each primer, 2 μl DNA and 1X of
the GoTaq Green MMX (Promega, USA).
The thermal cycling program for detection of both
genes was as follows: one cycle of initial denaturation at
95 °C for 5 min; 34 cycles of denaturation at 95 °C for
30s, annealing at 60 °C for 30s, and extension at 72 °C
for 1 min followed by a final extension at 72 °C for
5 min. The amplified products (femA: 306 bp and mecA:
402 bp) were resolved on a 2% agarose gel. The frag-
ments were stained with ethidium bromide and visual-
ized and photographed using gel documentation system.
A 100 bp ladder was run as a molecular weight marker.
Another set of primers targeting the mecA gene was
used (forward: 5’- AAAATCGATGGTAAAGGTTGGC-
3’ and reverse: 5’-GTTCTGCAGTACCGGATTTGC-3’)
for confirmation of mecA gene expression using the
reaction components described above [18]. After initial
denaturation at 95 °C for 1 min, the samples were sub-
jected to 35 cycles of denaturation at 95 °C for 1 min,
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annealing at 54 °C for 1 min and extension at 72 °C for
1 min. A final extension was performed at 72 °C for
5 min. The expected amplicon size is 533 bp.
Positive and negative controls were added in each run,
we used reference strains that are mecA positive and
negative. S. aureus ATCC 33,592 (positive control for
mec gene, MRSA); S. aureus ATCC 29,213 negative
control.
Statistical analysis
The results were tabulated and analyzed using version
20 of the Statistical Package for the Social Sciences
(SPSS). Frequencies, cross tabulation and appropriate
statistical tests as Chi-square test and fisher exact test
were performed. A P-value of less than 0.05 was consid-
ered significant.
Results
Overall, 62 bacterial isolates were phenotypically identi-
fied as S. aureus as described in the materials and
methods. All of the 62 isolates were confirmed as S. aur-
eus by targeting the femA gene. Accordingly, the rate of
nasal carriage of S. aureus among HCWs is 31% (62/
200). Among them 51 (82.3%) were identified as MRSA
using the oxacillin disc resistance (≤11 mm; Table 1).
However, using PCR targeting the mecA gene in S. aur-
eus, only 40 isolates were confirmed as MRSA (Fig. 1).
The overall nasal carriage rate of MRSA was 25.5%
(51/200). S. aureus carriage rate was highest among
nurses 33.6% (42/125), whereas carriage among doctors
was 28% (14/50).
MRSA carriage rate was significantly highest (P = 0.001)
among nurses 30.4% (38/125) compared to other profes-
sions (Table 1). Moreover, 90% (38/42) of the isolates of S.
aureus carried by the nurses were MRSA. The carriage
rate among doctors was 16% (8/50).
The highest rate of S. aureus carriage was found in
HCWs of the internal medicine and emergency depart-
ments (44.8 and 44.4% respectively). On the other hand,
the highest MRSA carriage rate was found in internal
medicine and surgery wards (41.3 and 35% respectively;
Table 2). All of the 17 S. aureus isolates collected from
healthcare workers of the surgery department were
MRSA (100%). Additionally, 12 out of the 13 S. aureus
isolates obtained from healthcare workers of the internal
medicine department (92%) were MRSA (Table 2).
All S. aureus isolates (100%) were resistant to penicillin.
However, sensitivity was high, but with variable degrees,
to gentamicin, ciprofloxacin, rifampicin, clindamycin and
vancomycin (96.7, 90.3, 88.7, 88.7, and 85.4% respectively;
Table 3).
Similarly, high rate of resistance of MRSA isolates
against penicillin were noticed (100%). On the other
hand sensitivity of the MRSA isolates to gentamicin,
ciprofloxacin, rifampicin, clindamycin, tetracycline and
vancomycin was high (92.2, 88.2, 88.2, 86.3, 86.3 and
84.3%; Table 4). All MSSA isolates were suceptible to
gentamicin, cefuroxime, ciprofloxacin, rifampicin and
clindamycin (Table 4).
Discussion
Detection of MRSA nasal carriage among HCWs in
the hospital is necessary particularly for those work-
ing in the critical care areas. These individuals act as
a potential source of infection to their immunocom-
promised patients, resulting in their extended stay in
the hospital [19].
Health care workers (HCWs) are at the interface
between hospitals and communities. The survey for
MRSA carriage among HCWs has mostly been con-
ducted to investigate outbreaks or endemics but not
in non-outbreak situations [4]. For instance, the sub-
stantial proportion of children in Taiwan with nasal
MRSA colonization encouraged Huang et al to study
the carriage rate of MRSA among pediatricians who
cared for these children in non-outbreak situations.
Around seven percent of pediatricians in Taiwan har-
bored CA-MRSA in their nares [20].













Doctor 50 14(28%) 8(16%) 6(12%) 0.058
Nurses 125 42(33.6%) 38(30.4%) 4(3.2%)
Pharmacist 6 2(33.3%) 2(33.3%) 0
Radiologist 8 1(12.5%) 1(12.5%) 0
Technicians 11 3(27%) 2(18%) 1(9%)
Total 200 62(31%) 51(25.5%) 11(5.5%)
Legend: MRSA Methicillin resistant Staph aureus, MSSA Methicillin susceptible
Staph aureus
P value <0.05 statistically significant
Fig. 1 A representative result of mecA and femA PCR. Lane L: 100 bp DNA
ladder; lane 1: positive control; lanes 2, 3, 4 and 5 are tested isolates with
positively amplified mecA and femA genes; lanes 6, 7 and 8 are negative
for the mecA gene and positive for the femA gene; lane 9 is a blank
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Recently, a community-based nasal carriage among
healthy children and a hospital-based studies addressed
the epidemiology of S. aureus and MRSA in Gaza Strip
for the first time [9, 10] (Al Laham et al, 2015; Biber et
al. 2012). However, data regarding the epidemiology of S.
aureus and MRSA among HCWs in Gaza are very scant.
To the best of our knowledge, our study was the second
to address this topic.
In our study, the overall nasal carriage rate of S. aureus
and MRSA was 31 and 25.5% respectively. Our results are
comparable to those of a recent study that covered HCWs
of three different hospitals in Gaza Strip and found a
carriage rate of 42.1% for S. aureus and 22.6% for MRSA
[13]. Slight variations were found between the two
previous studies. In our study, nasal swabs were collected
from 200 health care personnel who are working at differ-
ent departments in Al Shifa hospital whereas in Al Laham
study, the nasal swabs were collected from 140 HCWs
from three different hospitals in Gaza. Moreover, in our
study we have determined the rate of MRSA nasal carriage
according to the professions among HCWs.
Our findings of S. aureus colonization among HCWs
are also comparable to the findings of other studies in
developing countries like Iran (31%; [21], Libya (39%;
[22], Pakistan (48%; [23] and India (50%; [24], or in
developed countries like Germany (33.8%; [25] and USA
(30, and 43.8%; [26, 27].
The estimated prevalence of MRSA in our study was
higher than that reported by studies conducted in
Nepal (3.4%; [28], Ethiopia (12.7%; [29], Iran (5.3 and
3.4%; [21, 28], and Bangalore (8%; [19]. Our reported
rate of S. aureus colonization is also higher than that
reported by other studies conducted in Arabic coun-
tries and other developing countries like Libya (12.4%;
[30], India (17.5%; [31], West Bank of Palestine (20.8%;
[11] and Kuwait (21%; [32].
Differences in the prevalence of nasal carriage of S.
aureus strains between countries and hospitals may be
explained in part by differences in the quality and size of
samples, the use of different microbiological methods
(from sampling technique to culture media) and differ-
ent interpretation guidelines. Moreover, different levels
of commitment to infection control measures may con-
tribute to these differences.
The frequency of MRSA carriage varies between hos-
pital wards. Our results showed that that 76% of the
Table 2 Distribution of S. aureus and MRSA isolates by wards/departments
Wards/ No of samples S. aureus (%) MRSA (%) MSSA (%) P. Value
Department (n = 200) (n = 62) (n = 51) (n = 11)
Surgery 48 17(35%) 17(35%) 0 0.019
Internal medicine 29 13(44.8%) 12(41.3%) 1(3.4%)
Emergency 27 12(44.44%) 8(25.9%) 4(14.8%)
Urology 11 1(9%) 0 1(9%)
Burn department 10 2(20%) 2(20%) 0
I.C.U 18 6(33.3%) 5(27.7%) 1(5.5%)
Pharmacy 6 2(33.3%) 2(33.3%) 0
X-ray 8 1(12.5%) 1(12.5%) 0
Laboratory 11 3(27%) 2(18%) 1(9%)
Chest department 6 1(16.6%) 1(16.6%) 0
Outpatient clinic 7 2(28.5%) 1(14.25%) 1(14.25%)
Maternity 13 1(7.7%) 1(7.7%) 0
Ear, nose and throat 6 2(33.3%) 0 2(33.3%)
Legend: MRSA Methicillin resistant Staph aureus, MSSA Methicillin susceptible Staph aureus
P value <0.05 statistically significant
Table 3 Antibiotic susceptibility pattern of S. aureus isolates
Antibiotics Susceptible (%) Intermediate (%) Resistant (%)
Oxacillin 11 (17.7%) 0 (0%) 51 (82.3%)
Penicillin 0 (0%) 0 (0%) 62 (100%)
Amoxicillin/clavulanic
acid
30 (48.4%) 1 (1.6%) 31 (50.0%)
Erythromycin 44 (80.0%) 7 (11.3%) 11 (17.8%)
Vancomycin 53 (85.5%) 0 9 (14.5%)
Tetracycline 53 (85.8%) 6 (9.8%) 3 (4.8%)
Cefuroxime 53 (85.8%) 6 (9.8%) 3 (4.8%)
Gentamycin 60 (96.8%) 1 (1.6%) 1 (1.6%)
Rifampicin 55 (88.7%) 4 (6.4%) 3 (4.8%)
Clindamycin 55 (88.7%) 5 (8.0%) 2 (3.2%)
Ciprofloxacin 56 (90.3%) 4 (6.4%) 2 (3.2%)
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MRSA carriers were working in the surgery and internal
medicine wards. All S. aureus isolates recovered from
the HCW of the surgery wards were MRSA whereas 12
out of 13 S. aureus isolates from the internal medicine
were MRSA. These two departments are well known for
their particularly high workload, crowdedness and rela-
tive shortage of HCWs.
Eradication of MRSA among the HCWs as well as im-
proving the infection control measures may help limiting
nosocomial transmission [33] although decolonization of
patients have recently been shown to be more effective
in high-endemicity settings [34].
Similarly, Khanel et al reported the HCWs from the
surgical wards and operating rooms accounted for 28.6%
of the MRSA carriers in Nepal [28].
In our study, the MRSA carriage was particularly high
among the nurses (30.4%), followed by doctors (16%).
This finding could be explained by the increased phys-
ical contact of nurses and doctors with patients and
overcrowding in surgery departments at Al Shifa
hospital which is a referral main tertiary hospital in the
Gaza Strip.
In concordance with our study, Shibabaw et al re-
ported the MRSA carriage was particularly high among
nurses (21.2%), doctors (12.5%) and laboratory techni-
cians (12.5%) [29]. In addition, in Nepal, MRSA carriage
was highest among nurses (7.8%) [28].
Recently a number of studies proposed using cefoxitin
to be superior in predicting the presence of mecA in S.
aureus and coagulase negative Staphylococci with a high
degree of sensitivity and specificity [35–37]. Cefoxitin
was suggested to be used as a surrogate for the oxacillin
disk diffusion test. In particular, cefoxitin would over-
come the failure of routine oxacillin disk diffusion tests
to detect heterogeneous MRSA populations, it is a good
inductor of penicillin binding protein 2a production in
S. aureus isolates that carry the mecA gene [36].
Out of 51 MRSA isolates detected by oxacillin diffusion
test, only 40 were confirmed by PCR. In agreement with
our results, the absence of mecA gene within resistant
staphylococcal isolates was reported worldwide [38–40].
For example, Elhassan et al reported twelve out of the 123
MRSA isolates (9.8%) were mecA negative when using
PCR targeting mecA gene [41]. Inconsistency between
phenotypic and genotypic findings may result from muta-
tions in the primers binding sites within the gene. For this
purpose we have used a different set of primers to target
the mecA gene [18]. However, the same results were
obtained. This may also be attributed to intrinsic factors
that compete with mecA gene in producing resistance
phenomenon in regions with high prevalence of MRSA.
Olayinka et al reported the complete absence of five major
SCCmec types and mecA genes as well as the gene product
of Penicillin binding protein 2a (PBP2a) in isolates which
were phenotypically MRSA suggesting a probability of
hyperproduction of β- lactamase as a cause of this
phenomenon [42]. The possible existence of mechanisms
other than presence of mecA gene requires further
investigation.
Our and others findings undermine the reliability of
mecA gene PCR in characterization of MRSA isolates, a
point that should be under consideration by regional
and reference laboratories.
In this study, the antibiogram profile of all S. aureus and
MRSA isolates showed 100% resistance to penicillin. This
pattern of resistance was shown in previous studies from
Gaza Strip and the West Bank [8, 9, 11] and was also re-
ported by others elsewhere [21–24, 29, 43, 44]. S. aureus
isolates showed 50% resistance to amoxicillin/clavulanic
acid. The resistance to the aforementioned antibiotics
Table 4 Antibiotic susceptibility pattern of MRSA and MSSA isolates
Antibiotic MRSA (n = 51), n (%) MSSA (n = 11), n (%)
S I R S I R
Oxacillin 0 0 51 (100%) 11 (100%) 0 0
Penicillin 0 0 51 (100%) 0 0 11 (100%)
Amoxicillin/ clavulanic acid 29 (56.9%) 0 22 (43.1%) 8 (72.7%) 0 3 (27.3%)
Erythromycin 33 (64.7%) 8 (15.7%) 10 (19.6%) 10 (90.9%) 0 1 (9.1%)
Vancomycin 43 (84.3%) 0 8 (15.7%) 10 (90.9%) 0 1 (9.1%)
Tetracycline 44 (86.3%) 2 (3.9%) 5 (9.8%) 9 (81.8%) 1 (9.1%) 1 (9.1%)
Cefuroxime 42 (82.4%) 6 (11.8%) 3 (5.9%) 11 (100%) 0 0
Gentamycin 47 (92.2%) 2 (3.9%) 2 (3.9%) 11 (100%) 0 0
Rifampicin 45 (88.2%) 3 (5.9%) 3 (5.88%) 11 (100%) 0 0
Clindamycin 44 (86.3) 5 (9.8%) 2 (3.92%) 11 (100%) 0 0
Ciprofloxacin 45 (88.2%) 4 (7.8%) 2 (3.92%) 11 (100%) 0 0
Legend: MRSA Methicillin resistant Staph aureus, MSSA Methicillin suceptible Staph aureus
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could be mainly due to excessive use, misuse, and ir-
rational prescription of these medication in Gaza Strip for
both hospital and community acquired infections as well
as in livestock. Furthermore, the lack of policies for anti-
biotic prescription, and the commercial availability of
antibiotics without a medical doctor prescription in our
country worsen the case. In view of the high resistance
rates of S. aureus to these aforementioned antibiotics,
treatment of S. aureus infections at our hospitals with
these antibiotics may not be effective.
On the other hand, S. aureus isolates including both
MRSA and MSSA, were mostly susceptible to vanco-
mycin, tetracycline, gentamycin, rifampin and ciprofloxa-
cin. This could be due to the limited prescription and
use of these antibiotics in the community in Gaza Strip.
So, the full sensitivity to these microbial agents including
vancomycin can work perfectly against S. aureus and
MRSA infections in our community and hospitals as in-
dicated in recent studies in Gaza Strip [9, 10].
Surprisingly, 8 isolates of MRSA (15.7%) and one of
MSSA (9.1%) were found to be resistant to vancomycin
by disc diffusion test. These findings are alarming for
the presence of vancomycin-resistant S. aureus (VRSA)
among HCWs, which should be addressed in a future
larger study in Gaza hospitals.
It is noteworthy saying that our current study was
conducted in one hospital, however this hospital (Al-
Shifa) is a referral hospital serving the largest popula-
tion in Gaza strip. Moreover, we realize that our
study didn’t involve application of MIC and E-test for
vancomycin, as our goal was focusing in assessing the
extent of MRSA among HCW rather than assessment
of vancomycin sensitivity. MIC and E-test will be
applied in future studies involving a larger number of
health centers.
Conclusion
Nasal carriage of MRSA among HCWs is relatively high
in Al Shifa, the largest referral hospital in Gaza Strip,
particularly among nurses and doctors and in surgery
and in internal medicine wards.
These findings highlight the urge for application and
adherence to infection control measures that aim at
reducing spread of infection by MRSA among suscep-
tible individuals who are highly vulnerable to be infected
with MRSA. Active surveillance of MRSA in health care
settings is highly recommended.
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